TORI LIMITED - Financial Health Assessment

1. Financial Health Score: C+

Explanation: The patient shows encouraging signs of recovery after a period of illness, with a significant return to profitability in FY2025. However, critical vital signs—particularly cash reserves and liquidity—remain concerning. The company is stabilizing but still requires careful monitoring and remedial action before it can be considered financially healthy.

2. Key Vital Signs

Profitability: 🟢 Improving

The patient has made a dramatic recovery from loss to profit—a swing of over £900,000 year-on-year. This is the financial equivalent of a fever breaking. Retained earnings have moved from deeply negative to positive territory.

Liquidity: 🔴 Critical Concern

Cash has halved to under £100,000—dangerously low for a company with £2.3 million in current liabilities. The quick ratio of 0.04x means the company has only 4p in immediately available cash for every £1 of short-term obligations. This is the financial equivalent of a patient with dangerously low blood pressure.

Working Capital: 🟡 Weak but Positive

Working capital has improved from negative to positive—another positive sign. However, 82% of total assets are trade receivables (£2.84M of £3.44M). The company's financial health is heavily dependent on collecting money owed by customers.

Leverage: 🟢 Improving

Debt has been substantially reduced—current borrowings fell from £513,889 to £140,000. The company has been paying down its debts aggressively, which is excellent for long-term health.

Cash Flow: 🟡 Moderate

Operating cash flow has improved significantly, though interest costs consume 35% of operating cash (£136K of £389K). This is like a patient whose medication costs are eating into their recovery resources.

3. Diagnosis

Primary Diagnosis: Post-Crisis Recovery with Chronic Liquidity Weakness

The financial data reveals a company that has turned a corner after what appears to have been a difficult period. The transition from a £119K loss to a £783K profit represents genuine improvement. However, several underlying conditions require attention:

Symptom 1: Receivables Dependency (The "Blocked Artery") With £2.84M in trade receivables representing 82% of total assets, TORI LIMITED is critically dependent on collecting from customers. If even 10% of these receivables prove uncollectible (£284K), it would eliminate the entire cash reserve and retained earnings. This concentration risk is the single biggest threat to financial health.

Symptom 2: Cash Starvation Despite Profitability The paradox of strong profits but declining cash (£179K → £98K) suggests the company is profit-rich but cash-poor. This typically occurs when revenue is recognized but cash collection lags—essentially, the company is financing its customers' operations.

Symptom 3: Interest Burden Interest payments of £136K represent a significant drain. While reduced from prior years, this cost consumed over half of net operating cash flow. The patient is still paying for past financial decisions.

Symptom 4: Governance Changes Multiple directors and secretaries resigned in February-March 2026, including Martin Harvey who holds 25-50% of shares. This could indicate restructuring, change of control, or internal disagreement—any of which could affect future stability.

Symptom 5: Deferred Tax Asset Significance The £506K deferred tax asset (down from £718K) represents future tax benefits but also confirms the company has accumulated significant past losses. While this asset is realizable, it reflects the depth of previous financial illness.

Historical Context

The long-term trend shows a company that has contracted significantly from its 2014 position: - 2014: Net assets £1.27M, Cash £1.51M - 2025: Net assets £1.07M, Cash £0.098M

While net assets have partially recovered, cash reserves are a fraction of historical levels.

4. Recommendations

Immediate (0-3 months): Stabilize the Patient

1. Accelerate Receivables Collection: Implement aggressive credit control procedures. Offer early payment discounts (2-3%) to accelerate cash inflow. The £2.84M in receivables is the company's lifeline—ensure it's being collected promptly.

2. Establish a Cash Buffer: Target a minimum cash reserve of £250K (approximately 3 months of operating costs). Consider negotiating extended payment terms with key suppliers temporarily to preserve cash.

3. Review Credit Risk: Assess the collectibility of the £2.84M receivables. Identify any provisions that may be needed and age the debtors to understand collection risk.

Short-term (3-12 months): Build Resilience

4. Reduce Interest Costs: With borrowings reduced to £190K, explore refinancing options or accelerated repayment to eliminate the £136K annual interest burden. Even a partial reduction would significantly improve cash flow.

5. Improve Cash Conversion: Target a reduction in days sales outstanding (DSO). If receivables represent approximately 3-4 months of revenue, aim to reduce this to 2 months through better invoicing and collection practices.

6. Review the Deferred Tax Asset: Work with tax advisors to understand the timing and likelihood of realizing the £506K deferred tax asset. This may provide future cash benefits but should not be relied upon for current liquidity.

Medium-term (1-2 years): Strengthen Constitution

7. Diversify Asset Base: The current over-reliance on receivables creates concentration risk. Consider whether some receivables could be factored or whether the business model can be adjusted to improve cash conversion.

8. Monitor Governance Stability: Understand the implications of recent officer resignations. Ensure continuity of management and clear strategic direction under the remaining directors (Dieter Scott Friedrichhs and Susan Elizabeth Knight).

9. Build Retained Earnings: Continue the profitability trend and resist the temptation to distribute profits until cash reserves and working capital are at healthy levels.

Risk Assessment